669
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis

, , , &

References

  • Ai, W., Zhang, Y., Tang, Q. Z., Yan, L., Bian, Z. Y., Liu, C., Huang, H., Bai, X., Yin, L., and Li, H. (2010). Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. J. Cell Biochem. 110:1111–1122.
  • Alenghat, F. J., and Ingber, D. E. (2002). Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci. Signal. 2002:pe6.
  • Anania, C. A., Stewart, E. A., Quade, B. J., Hill, J. A., and Nowak, R. A. (1997). Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol. Hum. Reprod. 3:685–691.
  • Aoki, F., Kurabayashi, M., Hasegawa, Y., and Kojima, I. (2005). Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am. J. Respir. Crit. Care Med. 172:713–720.
  • Arici, A., and Sozen, I. (2000). Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil. Steril. 73:1006–1011.
  • Arici, A., and Sozen, I. (2003). Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma. Am. J. Obstet. Gynecol. 188:76–83.
  • Beanes, S. R., Dang, C., Soo, C., and Ting, K. (2003). Skin repair and scar formation: The central role of TGF-beta. Expert Rev. Mol. Med. 5:1–22.
  • Bitencourt, S., de Mesquita, F. C., Caberlon, E., da Silva, G. V., Basso, B. S., Ferreira, G. A., and de Oliveira, J. R. (2012). Capsaicin induces de-differentiation of activated hepatic stellate cell. Biochem. Cell Biol. 90:683–690.
  • Boehm, K. D., Daimon, M., Gorodeski, I. G., Sheean, L. A., Utian, W. H., and Ilan, J. (1990). Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol. Reprod. Dev. 27:93–101.
  • Branton, M. H., and Kopp, J. B. (1999). TGF-beta and fibrosis. Microbes. Infect. 1:1349–1365.
  • Brown, L. F., Detmar, M., Tognazzi, K., Abu-Jawdeh, G., and Iruela-Arispe, M. L. (1997). Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 76:245–255.
  • Bussolino, F., Mantovani, A., and Persico, G. (1997). Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22:251–256.
  • Buttram Jr, V. C., and Reiter, R. C. (1981). Uterine leiomyomata: etiology, symptomatology, and management. Fertil. Steril. 36:433–445.
  • Cai, J., Yi, F. F., Bian, Z. Y., Shen, D. F., Yang, L., Yan, L., Tang, Q. Z., Yang, X. C., and Li, H. (2009). Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway. J. Cell Mol. Med. 13:909–925.
  • Cardozo, E. R., Clark, A. D., Banks, N. K., Henne, M. B., Stegmann, B. J., and Segars, J. H. (2012). The estimated annual cost of uterine leiomyomata in the United States. Am. J. Obstet. Gynecol. 206:211. e1-211. e9.
  • Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9:653–660.
  • Catherino, W. H., Leppert, P. C., Stenmark, M. H., Payson, M., Potlog-Nahari, C., Nieman, L. K., and Segars, J. H. (2004). Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes. Chromosomes Cancer. 40:204–217.
  • Catherino, W. H., Parrott, E., and Segars, J. (2011). Proceedings from the National Institute of Child Health and Human Development Conference on the Uterine Fibroid Research Update Workshop. Fertil. Steril. 95:9–12.
  • Chakir, J., Shannon, J., Molet, S., Fukakusa, M., Elias, J., Laviolette, M., Boulet, L.-P., and Hamid, Q. (2003). Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111:1293–1298.
  • Chang, H. L., Senaratne, T. N., Zhang, L. H., Szotek, P. P., Stewart, E., Dombkowski, D., Preffer, F., Donahoe, P. K., and Teixeira, J. (2010). Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reprod. Sci. 17:158–167.
  • Chaudhuri, V., Zhou, L., and Karasek, M. (2007). Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: A potential role in skin fibrogenesis. J. Cutan. Pathol. 34:146–153.
  • Chegini, N. (2010). Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin. Reprod. Med. 28:180–203.
  • Chegini, N., Luo, X., Ding, L., and Ripley, D. (2003). The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol. Cell Endocrinol. 209:9–16.
  • Chegini, N., Tang, X. M., and Ma, C. (1999). Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J. Clin. Endocrinol. Metab. 84:4138–4143.
  • Chegini, N., Zhao, Y., Williams, R. S., and Flanders, K. C. (1994). Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites. Endocrinology. 135:439–449.
  • Chen, H.-M., Lin, Y.-H., Cheng, Y.-M., Wing, L.-Y. C., and Tsai, S.-J. (2013a). Overexpression of integrin-beta1 in leiomyoma promotes cell spreading and proliferation. J. Clin. Endocrinol. Metab. 98:E837–E846.
  • Chen, X.-H., Sun, R.-S., Hu, J.-M., Mo, Z.-Y., Yang, Z.-F., Jin, G.-Y., Guan, W.-D., and Zhong, N.-S. (2009). Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice. Clin. Exp. Pharmacol. Physiol. 36:146–153.
  • Chen, Y.-T., Chang, F.-C., Wu, C.-F., Chou, Y.-H., Hsu, H.-L., Chiang, W.-C., Shen, J., Chen, Y.-M., Wu, K.-D., and Tsai, T.-J. (2011). Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 80:1170–1181.
  • Chen, Y., Nie, Y.-C., Luo, Y.-L., Lin, F., Zheng, Y.-F., Cheng, G.-H., Wu, H., Zhang, K.-J., Su, W.-W., Shen, J.-G., and Li, P.-B. (2013b). Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice. Food Chem. Toxicol. 58:133–140.
  • Chen, Y. H., Liang, C. M., Chen, C. L., Chen, J. T., Chang, Y. H., Lu, D. W., Chien, K. H., and Tai, M. C. (2013c). Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. Acta. Ophthalmol (Copenh). 97:e506–e515.
  • Chintharlapalli, S., Papineni, S., Ramaiah, S. K., and Safe, S. (2007). Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 67:2816–2823.
  • Cho, J.-W., Il, K.-J., and Lee, K.-S. (2013). Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: Potential therapeutic use in the chemoprevention of keloids. Int. J. Mol. Med. 31:1148–1152.
  • Chuang, T.-D., and Khorram, O. (2014). miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. PloS one. 9:e95370.
  • Chung, A. C. K., and Lan, H. Y. (2013). Molecular mechanisms of TGF-β signaling in renal fibrosis. Curr. Pathobiol. Rep. 1:291–299.
  • Ciarmela, P., Bloise, E., Gray, P. C., Carrarelli, P., Islam, M. S., De Pascalis, F., Severi, F. M., Vale, W., Castellucci, M., and Petraglia, F. (2011a). Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. J. Clin. Endocrinol. Metab. 96:755–765.
  • Ciarmela, P., Carrarelli, P., Islam, M. S., Janjusevic, M., Zupi, E., Tosti, C., Castellucci, M., and Petraglia, F. (2014). Ulipristal acetate modulates the expression and functions of activin A in leiomyoma cells. Reprod. Sci. 21:1120–1125.
  • Ciarmela, P., Islam, M. S., Reis, F. M., Gray, P. C., Bloise, E., Petraglia, F., Vale, W., and Castellucci, M. (2011b). Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum. Reprod. Update. 17:772–790.
  • Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., and Sorescu, D. (2005). NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97:900–907.
  • David, A. C., Sam, M., Nichole, M. B., William, W. H., and Arnold, I. C. (2012). Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition. Biochem J. 443:361–368.
  • Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., and Schectman, J. M. (2003). High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am. J. Obstet. Gynecol. 188:100–107.
  • De Falco, M., Staibano, S., D'Armiento, F. P., Mascolo, M., Salvatore, G., Busiello, A., Carbone, I. F., Pollio, F., and Di Lieto, A. (2006). Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor. J. Soc. Gynecol. Investig. 13:297–303.
  • Deep, G., Kumar, R., Jain, A. K., Agarwal, C., and Agarwal, R. (2014). Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling. Mutat. Res. 768:35–46.
  • Desmouliere, A., Chaponnier, C., and Gabbiani, G. (2005). Tissue repair, contraction, and the myofibroblast. Wound Repair. Regen. 13:7–12.
  • Desmouliere, A., Redard, M., Darby, I., and Gabbiani, G. (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146:56–66.
  • Di Lieto, A., De Falco, M., Mansueto, G., De Rosa, G., Pollio, F., and Staibano, S. (2005). Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern. Steroids. 70:95–102.
  • Di Lieto, A., De Falco, M., Staibano, S., Iannotti, F., Scaramellino, M., Salvatore, G., Mansueto, G., Granata, P., Pontillo, M., and Pollio, F. (2003). Effects of gonadotropin-releasing hormone agonists on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas. Int. J. Gynecol. Pathol. 22:353–358.
  • di Mola, F. F., Friess, H., Scheuren, A., Di Sebastiano, P., Graber, H., Egger, B., Zimmermann, A., Korc, M., and Büchler, M. W. (1999). Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease. Ann. Surg. 229:67–75.
  • DiDonato, J. A., Mercurio, F., and Karin, M. (2012). NF-κB and the link between inflammation and cancer. Immunol. Rev. 246:379–400.
  • Dimitrova, I. K., Richer, J. K., Rudolph, M. C., Spoelstra, N. S., Reno, E. M., Medina, T. M., and Bradford, A. P. (2009). Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient. Fertil. Steril. 91:2650–2663.
  • Ding, L., Luo, X., and Chegini, N. (2004a). The expression of IL-13 and IL-15 in leiomyoma and myometrium and their influence on TGF-β and proteases expression in leiomyoma and myometrial smooth muscle cells and SKLM, leiomyosarcoma cell line. J. Soc. Gynecol. Investig. 11:319A.
  • Ding, L., Xu, J., Luo, X., and Chegini, N. (2004b). Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J. Clin. Endocrinol. Metab. 89:5549–5557.
  • Dixon, D., He, H., and Haseman, J. K. (2000). Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ. Health Perspect. 108(Suppl 5):795–802.
  • Dong, M.-X., Jia, Y., Zhang, Y.-B., Li, C.-C., Geng, Y.-T., Zhou, L., Li, X.-Y., Liu, J.-C., and Niu, Y.-C. (2009). Emodin protects rat liver from CCl4-induced fibrogenesis via inhibition of hepatic stellate cells activation. World J. Gastroenterol. 15:4753–4762.
  • Donnez, J., Hudecek, R., Donnez, O., Matule, D., Arhendt, H. J., Zatik, J., Kasilovskiene, Z., Dumitrascu, M. C., Fernandez, H., Barlow, D. H., Bouchard, P., Fauser, B. C., Bestel, E., Terrill, P., Osterloh, I., and Loumaye, E. (2015). Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil. Steril. 103:519–27 e3.
  • Donnez, J., Tatarchuk, T. F., Bouchard, P., Puscasiu, L., Zakharenko, N. F., Ivanova, T., Ugocsai, G., Mara, M., Jilla, M. P., and Bestel, E. (2012a). Ulipristal acetate versus placebo for fibroid treatment before surgery. N. Engl. J. Med. 366:409–420.
  • Donnez, J., Tomaszewski, J., Vázquez, F., Bouchard, P., Lemieszczuk, B., Baró, F., Nouri, K., Selvaggi, L., Sodowski, K., and Bestel, E. (2012b). Ulipristal acetate versus leuprolide acetate for uterine fibroids. N. Engl. J. Med. 366:421–432.
  • Dou, Q., Zhao, Y., Tarnuzzer, R. W., Rong, H., Williams, R. S., Schultz, G. S., and Chegini, N. (1996). Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J. Clin. Endocrinol. Metab. 81:3222–3230.
  • Downes, E., Sikirica, V., Gilabert-Estelles, J., Bolge, S. C., Dodd, S. L., Maroulis, C. and Subramanian, D. (2010). The burden of uterine fibroids in five European countries. Eur. J. Obstet. Gynecol. Reprod. Biol. 152:96–102.
  • Duvernelle, C., Freund, V. r., and Frossard, N. (2003). Transforming growth factor-beta and its role in asthma. Pulm. Pharmacol. Ther. 16:181–196.
  • Dye, J. F., Lawrence, L., Linge, C., Leach, L., Firth, J. A., and Clark, P. (2004). Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition. Endothelium. 11:151–167.
  • Ebert, S., Zeretzke, M., Nau, R., and Michel, U. (2007). Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists. Neurosci. Lett. 413:241–244.
  • Elsharkawy, A. M., and Mann, D. A. (2007). Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology. 46:590–597.
  • Eramaa, M., Hurme, M., Stenman, U. H., and Ritvos, O. (1992). Activin A/erythroid differentiation factor is induced during human monocyte activation. J. Exp. Med. 176:1449–1452.
  • Fang, J., Xia, C., Cao, Z., Zheng, J. Z., Reed, E., and Jiang, B.-H. (2005). Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 19:342–353.
  • Fayed, Y. M., Tsibris, J. C., Langenberg, P. W., and Robertson, A. L., Jr. (1989). Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab. Invest. 60:30–37.
  • Ferrara, N., and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocr. Rev. 18:4–25.
  • Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., and Kitani, A. (2005). IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat. Med. 12:99–106.
  • Fletcher, N. M., Saed, M. G., Abu-Soud, H. M., Al-Hendy, A., Diamond, M. P., and Saed, G. M. (2013). Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids. J. Assist. Reprod. Genet. 30:969–974.
  • Fletcher, N. M., Saed, M. G., Abuanzeh, S., Abu-Soud, H. M., Al-Hendy, A., Diamond, M. P., and Saed, G. M. (2014). Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma. Reprod. Sci. 21:1145–1152.
  • Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:4–7.
  • Franzen, C. A., Amargo, E., Todorović, V., Desai, B. V., Huda, S., Mirzoeva, S., Chiu, K., Grzybowski, B. A., Chew, T.-L., and Green, K. J. (2009). The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev. Res. (Phila). 2:830–841.
  • Friedman, A. J., Hoffman, D. I., Comite, F., Browneller, R. W., and Miller, J. D. (1991). Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Obstet. Gynecol. 77:720–725.
  • Fujisawa, C., and Castellot Jr, J. J. (2014). Matrix production and remodeling as therapeutic targets for uterine leiomyoma. J. Cell Commun. Signal. 8:179–194.
  • Fumagalli, M., Musso, T., Vermi, W., Scutera, S., Daniele, R., Alotto, D., Cambieri, I., Ostorero, A., Gentili, F., and Caposio, P. (2007). Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp. Dermatol. 16:600–610.
  • Funakoshi-Tago, M., Nakamura, K., Tago, K., Mashino, T., and Kasahara, T. (2011). Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin. Int. Immunopharmacol. 11:1150–1159.
  • Gabrielli, A., Svegliati, S., Moroncini, G., and Amico, D. (2012). New insights into the role of oxidative stress in scleroderma fibrosis. Open. Rheumatol. J. 6:87–95.
  • Garcia-Maceira, P., and Mateo, J. (2009). Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene. 28:313–324.
  • Geiger, B., Bershadsky, A., Pankov, R., and Yamada, K. M. (2001). Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2:793–805.
  • Gentry, C. C., Okolo, S. O., Fong, L. F., Crow, J. C., Maclean, A. B., and Perrett, C. W. (2001). Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. Clin. Sci. (Lond). 101:691–695.
  • Gheorgheosu, D., Jung, M., Ören, B., Schmid, T., Dehelean, C., Muntean, D., and Brüne, B. (2013). Betulinic acid suppresses NGAL-induced epithelial-to-mesenchymal transition in melanoma. Biol. Chem. 394:773–781.
  • Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-κB puzzle. Cell. 109:S81–S96.
  • Gong, J.-H., Cho, I.-H., Shin, D., Han, S.-Y., Park, S.-H., and Kang, Y.-H. (2013). Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice. Lab. Invest. 94:297–308.
  • Gorin, Y., Block, K., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J. L., and Abboud, H. E. (2005). Nox4 NAD (P) H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280:39616–39626.
  • Gressner, A. M., Weiskirchen, R., Breitkopf, K., and Dooley, S. (2002). Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7:d793–807.
  • Guo, J., Gu, N., Chen, J., Shi, T., Zhou, Y., Rong, Y., Zhou, T., Yang, W., Cui, X., and Chen, W. (2013). Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice. Arch. Toxicol. 87:1963–1973.
  • Guo, W., and Giancotti, F. G. (2004). Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5:816–826.
  • Ha, M.-K., Song, Y. H., Jeong, S.-J., Lee, H.-J., Jung, J. H., Kim, B., Song, H. S., Huh, J.-E., and Kim, S.-H. (2011). Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes. Biol. Pharm. Bull. 34:1432–1437.
  • Harrison-Woolrych, M. L., Sharkey, A. M., Charnock-Jones, D. S., and Smith, S. K. (1995). Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J. Clin. Endocrinol. Metab. 80:1853–1858.
  • Hassan, M. H., Eyzaguirre, E., Arafa, H. M. M., Hamada, F. M. A., Salama, S. A., and Al-Hendy, A. (2008). Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am. J. Obstet. Gynecol. 199:156. e1–156. e8.
  • Heldin, C.-H., and Westermark, B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79:1283–1316.
  • Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., and Cohen, C. D. (2007). Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117:3810–3820.
  • Hinz, B. (2006). Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur. J. Cell Biol. 85:175–181.
  • Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M. L., and Gabbiani, G. (2007). The myofibroblast: one function, multiple origins. Am. J. Pathol. 170:1807–1816.
  • Ho, Y. Y., Lagares, D., Tager, A. M., and Kapoor, M. (2014). Fibrosis-a lethal component of systemic sclerosis. Nat. Rev. Rheumatol. 10:390–402.
  • Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., and De Bruijn, E. A. (2004). Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56:549–580.
  • Holdsworth-Carson, S. J., Zaitseva, M., Vollenhoven, B. J., and Rogers, P. A. W. (2014). Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol. Hum. Reprod. 20:250–259.
  • Hou, P., Zhao, L., Li, Y., Luo, F., Wang, S., Song, J., and Bai, J. (2014). Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium. Mol. Hum. Reprod. 20:148–154.
  • Hu, X. W., Meng, D., and Fang, J. (2008). Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis. 29:2369–2376.
  • Hua, R., Pease, J. E., Sooranna, S. R., Viney, J. M., Nelson, S. M., Myatt, L., Bennett, P. R., and Johnson, M. R. (2012). Stretch and inflammatory cytokines drive myometrial chemokine expression via NF-κB activation. Endocrinology. 153:481–491.
  • Hubner, G., Brauchle, M., Gregor, M., and Werner, S. (1997). Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab. Invest. 77:311–318.
  • Islam, M. S., Akhtar, M. M., Ciavattini, A., Giannubilo, S. R., Protic, O., Janjusevic, M., Procopio, A. D., Segars, J. H., Castellucci, M., and Ciarmela, P. (2014a). Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: Promising options for prevention and treatment of uterine fibroids? Mol. Nutr. Food Res. 58:1667–1684.
  • Islam, M. S., Catherino, W. H., Protic, O., Janjusevic, M., Gray, P. C., Giannubilo, S. R., Ciavattini, A., Lamanna, P., Tranquilli, A. L., Petraglia, F., Castellucci, M., and Ciarmela, P. (2014b). Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. J. Clin. Endocrinol. Metab. 99:E775–E785.
  • Islam, M. S., Protic, O., Stortoni, P., Grechi, G., Lamanna, P., Petraglia, F., Castellucci, M., and Ciarmela, P. (2013a). Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil. Steril. 100:178–193.
  • Islam, M. S., Protic, O., Toti, P., Giannubilo, S. R., Tranquilli, A. L., Petraglia, F., Castellucci, M., and Ciarmela, P. (2013b). Uterine leiomyoma: available medical treatments and new possible therapeutic options. J. Clin. Endocrinol. Metab. 98:921–934.
  • Iwahashi, M., and Muragaki, Y. (2011). Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle. Fertil. Steril. 95:2137–2139.
  • Jinnin, M., Ihn, H., Mimura, Y., Asano, Y., Yamane, K., and Tamaki, K. (2005). Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts. J. Cell Physiol. 202:510–517.
  • Jones, K. L., Mansell, A., Patella, S., Scott, B. J., Hedger, M. P., de Kretser, D. M., and Phillips, D. J. (2007). Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc. Natl. Acad. Sci. U S A. 104:16239–16244.
  • Joseph, D. S., Malik, M., Nurudeen, S., and Catherino, W. H. (2010). Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3. Fertil. Steril. 93:1500–1508.
  • Jourdan-LeSaux, C., Zhang, J., and Lindsey, M. L. (2010). Extracellular matrix roles during cardiac repair. Life Sci. 87:391–400.
  • Jung, H.-J., Park, J.-W., Lee, J. S., Lee, S.-R., Jang, B.-C., Suh, S.-I., Suh, M.-H., and Baek, W.-K. (2009). Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells. Biochem. Biophys. Res. Commun. 390:71–76.
  • Kamata, H. and Hirata, H. (1999). Redox regulation of cellular signalling. Cell Signal. 11:1–14.
  • Kang, H.-R., Cho, S. J., Lee, C. G., Homer, R. J., and Elias, J. A. (2007). Transforming growth factor (TGF)-β1 stimulates pulmonary fibrosis and inflammation via a bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J. Biol. Chem. 282:7723–7732.
  • Kang, O.-H., Lee, J.-H., and Kwon, D.-Y. (2011). Apigenin inhibits release of inflammatory mediators by blocking the NF-κB activation pathways in the HMC-1 cells. Immu. Immunot. 33:473–479.
  • Karagiannidis, C., Hense, G., Martin, C., Epstein, M., Ruckert, B., Mantel, P. Y., Menz, G., Uhlig, S., Blaser, K., and Schmidt-Weber, C. B. (2006). Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J. Allergy Clin. Immunol. 117:111–118.
  • Karna, E., and Palka, J. A. (2009). Mechanism of betulinic acid inhibition of collagen biosynthesis in human endometrial adenocarcinoma cells. Neoplasma. 56:361–366.
  • Karna, E., Szoka, L., and Palka, J. A. (2010). Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Mol. Cell Biochem. 340:15–20.
  • Khanjani, S., Terzidou, V., Johnson, M. R., and Bennett, P. R. (2012). NFκB and AP-1 drive human myometrial IL8 expression. Mediators Inflamm. 2012:504952.
  • Kim, C.-S., Kawada, T., Kim, B.-S., Han, I.-S., Choe, S.-Y., Kurata, T., and Yu, R. (2003). Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal. 15:299–306.
  • Kim, D., Ramachandran, S., Baek, S., Kwon, S. H., Kwon, K. Y., Cha, S. D., Bae, I., and Cho, C. H. (2008). Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod. Sci. 15:552–558.
  • Kim, M. S., Park, M. J., Kim, S. J., Lee, C. H., Yoo, H., Shin, S. H., Song, E. S., and Lee, S. H. (2005). Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int. J. Oncol. 27:839–846.
  • Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., and Gauldie, J. (2001). Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107:1529.
  • Kourembanas, S., Marsden, P. A., McQuillan, L. P., and Faller, D. V. (1991). Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest. 88:1054–1057.
  • Kurachi, O., Matsuo, H., Samoto, T., and Maruo, T. (2001). Tumor necrosis factor-α expression in human uterine leiomyoma and its down-regulation by progesterone. J. Clin. Endocrinol. Metab. 86:2275–2280.
  • Kwon, H. J., Shim, J. S., Kim, J. H., Cho, H. Y., Yum, Y. N., Kim, S. H., and Yu, J. (2002). Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn. J. Cancer Res. 93:417–425.
  • Leask, A., and Abraham, D. J. (2004). TGF-β signaling and the fibrotic response. FASEB J. 18:816–827.
  • Leather, A. T., Studd, J. W. W., Watson, N. R., and Holland, E. F. N. (1993). The prevention of bone loss in young women treated with GnRH analogues with “add-back” estrogen therapy. Obstet. Gynecol. 81:104–107.
  • LeBleu, V. S., and Kalluri, R. (2011). Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis. Kidney Int. 80:1119–1121.
  • Lee, J., Jung, E., Lee, J., Huh, S., Hwang, C.-H., Lee, H.-Y., Kim, E.-J., Cheon, J.-M., Hyun, C. G., and Kim, Y. S. (2006). Emodin inhibits TNF α-induced MMP-1 expression through suppression of activator protein-1 (AP-1). Life Sci. 79:2480–2485.
  • Lee, S. H., Nan, J.-X., Zhao, Y. Z., Woo, S. W., Park, E.-J., Kang, T.-H., Seo, G. S., Kim, Y.-C., and Sohn, D. H. (2003). The chalcone butein from Rhus verniciflua shows antifibrogenic activity. Planta. Med. 69:990–994.
  • Leibovich, S. J., and Ross, R. (1975). The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 78:71–100.
  • Leppert, P., Fouany, M., and Segars, J. H. (2013). Understanding uterine fibroids. In: Fibroids, pp. 1–10. Segars, J. H., Ed.,, John Wiley & Sons, Ltd, Oxford.
  • Leppert, P. C., Baginski, T., Prupas, C., Catherino, W. H., Pletcher, S., and Segars, J. H. (2004). Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil. Steril. 82(Suppl 3):1182–1187.
  • Leppert, P. C., Catherino, W. H., and Segars, J. H. (2006). A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am. J. Obstet. Gynecol. 195:415–420.
  • Levens, E., Luo, X., Ding, L., Williams, R. S., and Chegini, N. (2005). Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Mol. Hum. Reprod. 11:489–494.
  • Li, M., Liu, Y., Jin, F., Sun, X., Li, Z., Liu, Y., Fang, P., Shi, H., and Jiang, X. (2012). Endothelin-1 induces hypoxia inducible factor 1α expression in pulmonary artery smooth muscle cells. FEBS Lett. 586:3888–3893.
  • Li, Q.-Y., Zhu, Y.-F., Zhang, M., Chen, L., Zhang, Z., Du, Y.-L., Ren, G.-Q., Tang, J.-M., Zhong, M.-K., and Shi, X.-J. (2015). Chlorogenic acid inhibits hypoxia-induced pulmonary artery smooth muscle cells proliferation via c-Src and Shc/Grb2/ERK2 signaling pathway. Eur. J. Pharmacol. 751:81–88.
  • Li, X., Liu, W., Wang, Q., Liu, P., Deng, Y., Lan, T., Zhang, X., Qiu, B., Ning, H., and Huang, H. (2009). Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol. Cell Endocrinol. 307:157–162.
  • Liang, M., Wang, H., Zhang, Y., Lu, S., and Wang, Z. (2006). Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata. Cancer Biol. Ther. 5:28–33.
  • Lin, C. H., Li, C. H., Liao, P. L., Tse, L. S., Huang, W. K., Cheng, H. W., and Cheng, Y. W. (2013). Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway. Br. J. Pharmacol. 168:920–931.
  • Lindahl, G. E., Chambers, R. C., Papakrivopoulou, J., Dawson, S. J., Jacobsen, M. C., Bishop, J. E., and Laurent, G. J. (2002). Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J. Biol. Chem. 277:6153–6161.
  • Liu, Y., Munker, S., Müllenbach, R., and Weng, H.-L. (2012). IL-13 signaling in liver fibrogenesis. Front Immunol. 3:116.
  • Luo, H., Rankin, G. O., Liu, L., Daddysman, M. K., Jiang, B.-H., and Chen, Y. C. (2009). Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr. Cancer. 61:554–563.
  • Luo, X., Ding, L., and Chegini, N. (2006). CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells. Mol. Hum. Reprod. 12:245–256.
  • Luo, X., Ding, L., Xu, J., and Chegini, N. (2005). Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology. 146:1097–1118.
  • Malik, M., Mendoza, M., Payson, M., and Catherino, W. H. (2009). Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil. Steril. 91:2177–2184.
  • Malik, M., Norian, J., McCarthy-Keith, D., Britten, J., and Catherino, W. H. (2010). Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin. Reprod. Med. 28:169–179.
  • Malik, M., Segars, J., and Catherino, W. H. (2012). Integrin β1 regulates leiomyoma cytoskeletal integrity and growth. Matrix. Biol. 31:389–397.
  • Mangrulkar, R. S., Ono, M., Ishikawa, M., Takashima, S., Klagsbrun, M., and Nowak, R. A. (1995). Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol. Reprod. 53:636–646.
  • Manoury, B., Nenan, S., Leclerc, O., Guenon, I., Boichot, E., Planquois, J.-M., Bertrand, C. P., and Lagente, V. (2005). The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir. Res. 6:11.
  • Mas, A., Cervello, I., Gil-Sanchis, C., and Simón, C. (2014). Current understanding of somatic stem cells in leiomyoma formation. Fertil. Steril. 102:613–620.
  • Mas, A., Nair, S., Laknaur, A., Simon, C., Diamond, M. P., and Al-Hendy, A. (2015). Stro-1/CD44 as putative human myometrial and fibroid stem cell markers. Fertil. Steril. 104:225–34.e3.
  • Matsuse, T., Ikegami, A., Ohga, E., Hosoi, T., Oka, T., Kida, K., Fukayama, M., Inoue, S., Nagase, T., and Ouchi, Y. (1996). Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am. J. Pathol. 148:707.
  • Mayer, A., Höckel, M., Wree, A., Leo, C., Horn, L.-C., and Vaupel, P. (2008). Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res. 68:4719–4726.
  • Melis, G. B., Piras, B., Marotto, M. F., Orru, M. M., Maricosu, G., Pilloni, M., Guerriero, S., Angiolucci, M., Lello, S., and Paoletti, A. M. (2012). Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment. Expert Opin. Drug Metab. Toxicol. 8:901–908.
  • Mesquita, F. S., Dyer, S. N., Heinrich, D. A., Bulun, S. E., Marsh, E. E., and Nowak, R. A. (2010). Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol. Reprod. 82:341–351.
  • Michel, U., Ebert, S., Phillips, D., and Nau, R. (2003). Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur. J. Endocrinol. 148:559–564.
  • Min, J.-K., Han, K.-Y., Kim, E.-C., Kim, Y.-M., Lee, S.-W., Kim, O.-H., Kim, K.-W., Gho, Y. S., and Kwon, Y.-G. (2004). Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res. 64:644–651.
  • Moon, D.-O., Choi, Y. H., Moon, S.-K., Kim, W.-J., and Kim, G.-Y. (2010). Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells. Toxicol. In Vitro. 24:1927–1934.
  • Moore, A. B., Castro, L., Yu, L., Zheng, X., Di, X., Sifre, M. I., Kissling, G. E., Newbold, R. R., Bortner, C. D., and Dixon, D. (2007). Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration. Hum. Reprod. 22:2623–2631.
  • Moore, A. B., Yu, L., Swartz, C. D., Zheng, X., Wang, L., Castro, L., Kissling, G. E., Walmer, D. K., Robboy, S. J., and Dixon, D. (2010). Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture. Cell Commun. Signal. 8:10.
  • Mylonis, I., Lakka, A., Tsakalof, A., and Simos, G. (2010). The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions. Biochem. Biophys. Res. Commun. 398:74–78.
  • Nair, S., and Al-Hendy, A. (2011). Adipocytes enhance the proliferation of human leiomyoma cells via TNF-α proinflammatory cytokine. Reprod. Sci. 18:1186–1192.
  • Nicholas, C., Batra, S., Vargo, M. A., Voss, O. H., Gavrilin, M. A., Wewers, M. D., Guttridge, D. C., Grotewold, E., and Doseff, A. I. (2007). Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J. Immunol. 179:7121–7127.
  • Norian, J. M., Malik, M., Parker, C. Y., Joseph, D., Leppert, P. C., Segars, J. H., and Catherino, W. H. (2009). Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod. Sci. 16:1153–1164.
  • Norian, J. M., Owen, C. M., Taboas, J., Korecki, C., Tuan, R., Malik, M., Catherino, W. H., and Segars, J. H. (2012). Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biol. 31:57–65.
  • Ohnishi, N., Miyata, T., Ohnishi, H., Yasuda, H., Tamada, K., Ueda, N., Mashima, H., and Sugano, K. (2003). Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut. 52:1487–1493.
  • Ono, M., Maruyama, T., Masuda, H., Kajitani, T., Nagashima, T., Arase, T., Ito, M., Ohta, K., Uchida, H., and Asada, H. (2007). Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc. Natl. Acad. Sci. U S A. 104:18700–18705.
  • Ota, F., Maeshima, A., Yamashita, S., Ikeuchi, H., Kaneko, Y., Kuroiwa, T., Hiromura, K., Ueki, K., Kojima, I., and Nojima, Y. (2003). Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis. Rheum. 48:2442–2449.
  • Palmer, S. S., Haynes-Johnson, D., Diehl, T., and Nowak, R. A. (1998). Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J. Soc. Gynecol. Investig. 5:203–209.
  • Parameswaran, N., and Patial, S. (2010). Tumor necrosis factor-α signaling in macrophages. Crit. Rev. Eukaryot. Gene. Expr. 20:87–103.
  • Park, J.-Y., Kawada, T., Han, I.-S., Kim, B.-S., Goto, T., Takahashi, N., Fushiki, T., Kurata, T., and Yu, R. (2004). Capsaicin inhibits the production of tumor necrosis factor α by LPS-stimulated murine macrophages, RAW 264.7: a PPARγ ligand-like action as a novel mechanism. FEBS Lett. 572:266–270.
  • Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., and Boettiger, D. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell. 8:241–254.
  • Pawlowski, J. E., Taylor, D. S., Valentine, M., Hail, M. E., Ferrer, P., Kowala, M. C., and Molloy, C. J. (1997). Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J. Clin. Invest. 100:639–648.
  • Pekonen, F., Nyman, T., and Rutanen, E. M. (1993). Differential expression of keratinocyte growth factor and its receptor in the human uterus. Mol. Cell Endocrinol. 95:43–49.
  • Plewka, A., Madej, P., Plewka, D., Kowalczyk, A., Miskiewicz, A., Wittek, P., Leks, T., and Bilski, R. (2013). Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages. Folia. Histochem. Cytobiol. 51:73–83.
  • Poli, G. (2000). Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects. Med. 21:49–98.
  • Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., and West, A. B. (1999). Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. Cell Physiol. 277:C1–C19.
  • Protic, O., Toti, P., Islam, M. S., Occhini, R., Giannubilo, S. R., Catherino, W. H., Janjusevic, M., Lamanna, P., Cinti, S., Petraglia, F., Ciavattini, A., Gray, P. C., Castellucci, M., Hinz, B., and Ciarmela, P. (2015). Possible involvement of inflammatory/reparative processes in the development of uterine fibroids. Cell Tissue Res. Advance Access published November 27, 2015, doi: 10.1007/s00441-015-2324-3.
  • Ren, K., and Torres, R. (2009). Role of interleukin-1β during pain and inflammation. Brain Res. Rev. 60:57–64.
  • Rhee, S., and Grinnell, F. (2006). P21-activated kinase 1: convergence point in PDGF-and LPA-stimulated collagen matrix contraction by human fibroblasts. J. Cell Biol. 172:423–432.
  • Ricupero, D. A., Poliks, C. F., Rishikof, D. C., Kuang, P.-P., and Goldstein, R. H. (2001). Apigenin decreases expression of the myofibroblast phenotype. FEBS Lett. 506:15–21.
  • Risau, W. (1990). Angiogenic growth factors. Prog. Growth Factor Res. 2:71–79.
  • Rogers, R., Norian, J., Malik, M., Christman, G., Abu-Asab, M., Chen, F., Korecki, C., Iatridis, J., Catherino, W. H., and Tuan, R. S. (2008). Mechanical homeostasis is altered in uterine leiomyoma. Am. J. Obstet. Gynecol. 198:474. e1–474. e11.
  • Rukkumani, R., Priyanka, A., Sankar, P., and Menon, V. P. (2012). Ferulic acid influences hepatic expression pattern of matrix metalloproteinases during alcohol and PUFA induced toxicity. Eur. Rev. Med. Pharmacol. Sci. 16:2147–2153.
  • Sanci, M., Dikis, C., Inan, S., Turkoz, E., Dicle, N., and Ispahi, C. (2011). Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma. Acta. Histochem. 113:317–325.
  • Santulli, P., Even, M., Chouzenoux, S., Millischer, A.-E., Borghese, B., de Ziegler, D., Batteux, F. d. r., and Chapron, C. (2013). Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden. Hum. Reprod. 28:2126–2133.
  • Scutera, S., Riboldi, E., Daniele, R., Elia, A. R., Fraone, T., Castagnoli, C., Giovarelli, M., Musso, T., and Sozzani, S. (2008). Production and function of activin A in human dendritic cells. Eur. Cytokine. Netw. 19:60–68.
  • Sen, C. K., and Roy, S. (2010). Oxygenation state as a driver of myofibroblast differentiation and wound contraction: hypoxia impairs wound closure. J. Invest. Dermatol. 130:2701–2703.
  • Senturk, L. M., Sozen, I., Gutierrez, L., and Arici, A. (2001). Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma. Am. J. Obstet. Gynecol. 184:559–566.
  • Serini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., and Gabbiani, G. (1998). The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142:873–881.
  • Shao, L., Frigon, N. L., Jr., Sehy, D. W., Yu, A. L., Lofgren, J., Schwall, R., and Yu, J. (1992). Regulation of production of activin A in human marrow stromal cells and monocytes. Exp. Hematol. 20:1235–1242.
  • Shi, H., Dong, L., Bai, Y., Zhao, J., Zhang, Y., and Zhang, L. (2009). Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur. J. Pharmacol. 623:119–124.
  • Shin, J., Lee, H.-J., Jung, D.-B., Jung, J. H., Lee, H.-J., Lee, E.-O., Lee, S. G., Shim, B. S., Choi, S. H., and Ko, S. G. (2011). Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells. PLoS One. 6:e21492.
  • Shin, J., Lee, H.-J., Jung, D.-B., Jung, J. H., Lee, H.-J., Lee, E.-O., Lee, S. G., Shim, B. S., Choi, S. H., and Ko, S. G. (2013). Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells. PloS one. 6:e21492.
  • Singh, V., Jaini, R., Torricelli, A. A. M., Santhiago, M. R., Singh, N., Ambati, B. K., and Wilson, S. E. (2014). TGF beta and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo. Exp Eye Res. 121:35–40.
  • Song, Y., Zhu, L., and Li, M. (2013). Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice. Clinics. 68:1350–1357.
  • Sooranna, S. R., Engineer, N., Loudon, J. A. Z., Terzidou, V., Bennett, P. R., and Johnson, M. R. (2005). The mitogen-activated protein kinase dependent expression of prostaglandin h synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial cells: the differential effect of stretch and interleukin-1beta. J. Clin. Endocrinol. Metab. 90:3517–3527.
  • Sozen, I., Olive, D. L., and Arici, A. (1998). Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata. Fertil. Steril. 69:1095–1102.
  • Stewart, E. A. (2001). Uterine fibroids. Lancet. 357:293–298.
  • Stewart, E. A., Friedman, A. J., Peck, K., and Nowak, R. A. (1994). Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J. Clin. Endocrinol. Metab. 79:900–906.
  • Stovall, T. G., Muneyyirci-Delale, O., Summitt Jr, R. L., and Scialli, A. R. (1995). GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: A randomized controlled trial. The Leuprolide Study Group. Obstet. Gynecol. 86:65–71.
  • Sturrock, A., Cahill, B., Norman, K., Huecksteadt, T. P., Hill, K., Sanders, K., Karwande, S. V., Stringham, J. C., Bull, D. A., and Gleich, M. (2006). Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 290:L661–L673.
  • Sugiyama, M., Ichida, T., Sato, T., Ishikawa, T., Matsuda, Y., and Asakura, H. (1998). Expression of activin A is increased in cirrhotic and fibrotic rat livers. Gastroenterology. 114:550–558.
  • Suo, G., Jiang, Y., Cowan, B., and Wang, J. Y. (2009). Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth. Biol. Reprod. 81:749–758.
  • Suou, K., Taniguchi, F., Tagashira, Y., Kiyama, T., Terakawa, N., and Harada, T. (2011). Apigenin inhibits tumor necrosis factor α–induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells. Fertil. Steril. 95:1518–1521.
  • Syssoev, K. A., Kulagina, N. V., Chukhlovin, A. B., Morozova, E. B., and Totolian, A. A. (2008). Expression of mRNA for chemokines and chemokine receptors in tissues of the myometrium and uterine leiomyoma. Bull. Exp. Biol. Med. 145:84–89.
  • Szuster-Ciesielska, A., Mizerska-Dudka, M., Daniluk, J., and Kandefer-Szerszen„, M. (2013). Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress. J. Gastroenterol. 48:222–237.
  • Szuster-Ciesielska, A., Plewka, K., Daniluk, J., and Kandefer-Szerszeń, M. (2011a). Betulin and betulinic acid attenuate ethanol-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS), cytokine (TNF-α, TGF-β) production and by influencing intracellular signaling. Toxicology. 280:152–163.
  • Szuster-Ciesielska, A., Plewka, K., and Kandefer-Szerszeń, M. (2011b). Betulin, betulinic acid and butein are inhibitors of acetaldehyde-induced activation of liver stellate cells. Pharmacol Rep. 63:1109–1123.
  • Tadakawa, M., Takeda, T., Li, B., Tsuiji, K., and Yaegashi, N. (2015). The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells. Mol. Cell Endocrinol. 399:1–8.
  • Taketazu, F., Kato, M., Gobl, A., Ichijo, H., Ten Dijke, P., Itoh, J., Kyogoku, M., Rönnelid, J., Miyazono, K., and Heldin, C.-H. (1994). Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab. Invest. 70:620–630.
  • Tal, R., and Segars, J. H. (2014). The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum. Reprod. Update. 20:194–216.
  • Tang, X. M., Dou, Q., Zhao, Y., McLean, F., Davis, J., and Chegini, N. (1997). The expression of transforming growth factor-βs and TGF-β receptor mRNA and protein and the effect of TGF-βs on human myometrial smooth muscle cells in vitro. Mol. Hum. Reprod. 3:233–240.
  • Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R. A. (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3:349–363.
  • Toullec, A., Gerald, D., Despouy, G., Bourachot, B., Cardon, M., Lefort, S., Richardson, M., Rigaill, G., Parrini, M. C., and Lucchesi, C. (2010). Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol. Med. 2:211–230.
  • Treloar, S. A., Do, K.-A., O'Connor, V. M., O'Connor, D. T., Yeo, M. A., and Martin, N. G. (1999). Predictors of hysterectomy: an Australian study. Am. J. Obstet. Gynecol. 180:945–954.
  • Tsibris, J., Segars, J., Coppola, D., Mane, S., Wilbanks, G. D., O'Brien, W. F., and Spellacy, W. N. (2002). Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil. Steril. 78:114–121.
  • Tsigkou, A., Reis, F. M., Ciarmela, P., Lee, M. H., Jiang, B., Tosti, C., Shen, F. R., Shi, Z., Chen, Y. G., and Petraglia, F. (2015). Expression levels of myostatin and matrix metalloproteinase 14 mRNAs in uterine leiomyoma are correlated with dysmenorrhea. Reprod. Sci. 22:1597–1602.
  • Van Laethem, J.-L., Robberecht, P., Resibois, A., and Devière, J. (1996). Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology. 110:576–582.
  • Wada, W., Kuwano, H., Hasegawa, Y., and Kojima, I. (2004). The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology. 145:2753–2759.
  • Walker, C. L., and Stewart, E. A. (2005). Uterine fibroids: the elephant in the room. Science. 308:1589–1592.
  • Wallace, K., Chatman, K., Porter, J., Scott, J., Johnson, V., Moseley, J., and LaMarca, B. (2014). Enodthelin 1 is elevated in plasma and explants from patients having uterine leiomyomas. Reprod. Sci. 21:1196–1205.
  • Wan, Y., Wu, Y.-L., Lian, L.-H., Xie, W.-X., Li, X., OuYang, B.-Q., Bai, T., Li, Q., Yang, N., and Nan, J.-X. (2012). The anti-fibrotic effect of betulinic acid is mediated through the inhibition of NF-κB nuclear protein translocation. Chem. Biol. Interact. 195:215–223.
  • Wang, C.-H., Gao, Z.-Q., Ye, B., Cai, J.-T., Xie, C.-G., Qian, K.-D., and Du, Q. (2007a). Effect of emodin on pancreatic fibrosis in rats. World J. Gastroenterol. 13:378–382.
  • Wang, J., Liao, Y., Fan, J., Ye, T., Sun, X., and Dong, S. (2012). Apigenin inhibits the expression of IL-6, IL-8, and ICAM-1 in DEHP-stimulated human umbilical vein endothelial cells and in vivo. Inflammation. 35:1466–1476.
  • Wang, R., Wan, Q., Zhang, Y., Huang, F., Yu, K., Xu, D., Wang, Q., and Sun, J. (2007b). Emodin suppresses interleukin-1 beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK. Life Sci. 80:2481–2488.
  • Wang, Y., Feng, G., Wang, J., Zhou, Y., Liu, Y., Shi, Y., Zhu, Y., Lin, W., Xu, Y., and Li, Z. (2015). Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells. Hum. Reprod. 30:61–70.
  • Wegienka, G. (2012). Are uterine leiomyoma a consequence of a chronically inflammatory immune system? Med. Hypotheses. 79:226–231.
  • Welsh, S. J., Bellamy, W. T., Briehl, M. M., and Powis, G. (2002). The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62:5089–5095.
  • Werner, S., and Alzheimer, C. (2006). Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17:157–171.
  • Wettschureck, N., and Offermanns, S. (2002). Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J. Mol. Med. 80:629–638.
  • Wilson, K. M., Smith, A. I., and Phillips, D. J. (2006). Stimulatory effects of lipopolysaccharide on endothelial cell activin and follistatin. Mol. Cell Endocrinol. 253:30–35.
  • Wipff, P.-J., Rifkin, D. B., Meister, J.-J., and Hinz, B. (2007). Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179:1311–1323.
  • Wójcik, K. A., Skoda, M., Koczurkiewicz, P., Sanak, M., Czyz, J., and Michalik, M. (2013). Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations. Pharmacol. Rep. 65:164–172.
  • Wolanska, M., and Bankowski, E. (2006). Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth. Biochimie. 88:141–146.
  • Wolanska, M., and Bankowski, E. (2007). Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth. Eur. J. Obstet. Gynecol. Reprod. Biol. 130:238–244.
  • Wolanska, M., Sobolewski, K., Bańkowski, E., and Jaworski, S. (2004). Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecol. Obstet. Invest. 58:14–18.
  • Woo, S. W., Lee, S. H., Kang, H. C., Park, E. J., Zhao, Y. Z., Kim, Y. C., and Sohn, D. H. (2003). Butein suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. J. Pharm. Pharmacol. 55:347–352.
  • Wynn, T. A. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117:524–529.
  • Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199–210.
  • Wynn, T. A., and Ramalingam, T. R. (2012). Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat. Med. 18:1028–1040.
  • Xing, Z., Tremblay, G. M., Sime, P. J., and Gauldie, J. (1997). Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am. J. Pathol. 150:59–66.
  • Xu, J., Luo, X., and Chegini, N. (2003). Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J. Clin. Endocrinol. Metab. 88:1350–1361.
  • Xu, Q., Ohara, N., Chen, W., Liu, J., Sasaki, H., Morikawa, A., Sitruk-Ware, R., Johansson, E. D. B., and Maruo, T. (2006). Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells. Hum. Reprod. 21:2408–2416.
  • Xu, T., Pan, Z., Dong, M., Yu, C., and Niu, Y. (2015). Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways in vitro. Biochem. Pharmacol. 93:49–58.
  • Yeh, H.-I., and Wang, S.-W. (2013). Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway. Evid. Based Complement. Alternat. Med. 2013:943187.
  • Yin, P., Ono, M., Moravek, M. B., Coon, J. S., Navarro, A., Monsivais, D., Dyson, M. T., Druschitz, S. A., Malpani, S. S., and Serna, V. A. (2015). Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo. J. Clin. Endocrinol. Metab. 100:E601–E606.
  • Yndestad, A., Ueland, T., Oie, E., Florholmen, G., Halvorsen, B., Attramadal, H., Simonsen, S., Froland, S. S., Gullestad, L., Christensen, G., Damas, J. K., and Aukrust, P. (2004). Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation. 109:1379–1385.
  • Yu, L., Saile, K., Swartz, C. D., He, H., Zheng, X., Kissling, G. E., Di, X., Lucas, S., Robboy, S. J., and Dixon, D. (2008). Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol. Med. 14:264–275.
  • Zhan, Y., Wei, H., Wang, Z., Huang, X., Xu, Q., Li, D., and Lu, H. (2001). [Effects of emodin on hepatic fibrosis in rats]. Zhonghua. Gan. Zang. Bing. Za. Zhi. 9:235–236.
  • Zhang, D., Al-Hendy, M., Richard-Davis, G., Montgomery-Rice, V., Rajaratnam, V., and Al-Hendy, A. (2010). Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil. Steril. 94:1887–1893.
  • Zheng, L.-H., Cai, F.-F., Ge, I., Biskup, E., and Cheng, Z.-P. (2014). Stromal fibroblast activation and their potential association with uterine fibroids (Review). Oncol. Lett. 8:479–486.
  • Zhou, S., Yi, T., Shen, K., Zhang, B., Huang, F., and Zhao, X. (2011). Hypoxia: The driving force of uterine myometrial stem cells differentiation into leiomyoma cells. Med. Hypotheses. 77:985–986.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.